Hepion Pharmaceuticals
HEPA • NASDAQ
Hepion Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gary S. Stetz, with a market cap of $1.3M.
CEOGary S. Stetz
Next Earnings
Upcoming earnings announcement for Hepion Pharmaceuticals
Date
Friday, April 10, 2026 (in 1 week)
Timing
Before Market Open (7:40 AM New York)
Fiscal Period
Q4 2025
Earnings History
Past 12 earnings reports for Hepion Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 2025 | Q2 2025 | -$0.09 | — | - | — |  10-Q |
| Nov 14, 2024 | Q3 2024 | -$36.00 | — | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$34.00 | — | - | — | 10-Q |
| May 21, 2024 | Q1 2024 | -$28.00 | — | - | — | 10-Q |
| Apr 16, 2024 | Q4 2023 | -$121.00Est: -$131.50 | +8.0% | - | — | — |
| Nov 20, 2023 | Q3 2023 | -$137.00Est: -$108.00 | -26.9% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$184.00 | — | - | — | — |
| May 12, 2023 | Q1 2023 | -$174.00Est: -$82.00 | -112.2% | - | — | — |
| Apr 10, 2023 | Q4 2022 | -$130.00Est: -$140.00 | +7.1% | - | — | — |
| Nov 14, 2022 | Q3 2022 | -$110.00 | — | - | — | — |
| Aug 15, 2022 | Q2 2022 | -$260.00 | — | - | — | — |
| May 16, 2022 | Q1 2022 | -$90.00 | — | - | — | — |